Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors

Journal of Neurology

Volumn 263, Issue 3, 2016, Pages 492-498

  Bianchi, Maria Laura Ester ^a   Leoncini, Emanuele ^a   Masciullo, Marcella ^b   Modoni, Anna ^a   Gadalla, Shahinaz M ^c   Massa, Roberto ^d   Rastelli, Emanuele ^d   Terracciano, Chiara ^d   Antonini, Giovanni ^e   Bucci, Elisabetta ^e   Petrucci, Antonio ^f   Costanzi, Sandro ^f   Santoro, Massimo ^g   Boccia, Stefania ^a   Silvestri, Gabriella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^g IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Cancer; Myotonic dystrophy type 1; Risk factors; Thyroid disease; Tumor

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ANGIOMA; ARTICLE; BENIGN TUMOR; BODY MASS; BONE CANCER; BREAST CANCER; BULBAR PARALYSIS; CANCER RISK; CATARACT; CLINICAL FEATURE; COHORT ANALYSIS; COLON CANCER; DISEASE DURATION; FEMALE; GALLBLADDER CANCER; GROUPS BY AGE; HUMAN; HYPOTHYROIDISM; ITALY; KIDNEY CANCER; LIFESTYLE; LIPOMA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; MENINGIOMA; MIDDLE AGED; MOLECULAR DIAGNOSIS; MULTIPLE MYELOMA; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY CANCER; PAROTID GLAND CANCER; PILOMATRIXOMA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SKIN CANCER; SMOKING; THYMUS CANCER; THYROID CANCER; THYROID DISEASE; TOXIC GOITER; TRINUCLEOTIDE REPEAT; UTERUS CANCER; UTERUS MYOMA; ADOLESCENT; AGE DISTRIBUTION; CLASSIFICATION; NEOPLASMS; NONPARAMETRIC TEST; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COHORT STUDIES; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; NEOPLASMS; RISK FACTORS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84960419575     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-8006-y     Document Type: Article

References (30)

1. Ashizawa T, Sarkar PS (2011) Myotonic dystrophy types 1 and 2. Handb Clin Neurol 101:193–237
2. PS Harper (2001) Myotonic Dystrophy, 3rd edn. London
3. Cantwell AR Jr, Reed WB (1965) Myotonia atrophica and multiple calcifying epithelioma of Malherbe. Acta Derm Venereol 45:387–390
4. Street ML, Rogers RS 3rd (1991) Multiple pilomatricomas and myotonic dystrophy. J Dermatol Surg Oncol 17:728–730
5. Laredo Ortiz C, Munoz Romero F, Mallent Anon J, Domenech Miro E, Tafalla Pena M (1997) Multiple pilomatrixomas associated with Steinert disease. An Med Interna 14:409–411
6. Barberio E, Nino M, Dente V, Delfino M (2002) Guess what! Multiple pilomatricomas and Steiner disease. Eur J Dermatol 12:293–294
7. Gadalla SM, Lund M, Pfeiffer RM, Gørtz S, Mueller CM, Moxley RT 3rd, Kristinsson SY, Björkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH (2011) Cancer risk among patients with myotonic muscular dystrophy. JAMA 306:2480–2486
8. Win AK, Perattur PG, Pulido JS, Pulido CM, Lindor NM (2012) Increased cancer risks in myotonic dystrophy. Mayo Clin Proc 87:130–135
9. Mohamed S, Pruna L, Kaminsky P (2013) Increasing risk of tumors in myotonic dystrophy type 1. Presse Med 42:281–284
10. Das M, Moxley RT 3rd, Hilbert JE, Martens WB, Letren L, Greene MH, Gadalla SM (2012) Correlates of tumor development in patients with myotonic dystrophy. J Neurol 259:2161–2166
11. Gennarelli M, Pavoni M, Amicucci P, Novelli G, Dallapiccola B (1998) A single polymerase chain reaction-based protocol for detecting normal and expanded alleles in myotonic dystrophy. Diagn Mol Pathol 7:135–137
12. Modoni A, Silvestri G, Pomponi MG, Mangiola F, Tonali PA, Marra C (2004) Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch Neurol 61:1943–1947
13. [No authors listed] New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC) (2000) Neurology 54:1218-21
14. AIRTUM Working group (2011) Italian cancer figures, report 2011: survival of cancer patients in Italy. Epidemiol Prev 35:1–200
15. Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Hilbert JE, Moxley RT 3rd, Landgren O, Greene MH (2013) Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis. PLoS ONE 8:e79851
16. Okolo S (2008) Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22:571–588
17. Lund M, Diaz LJ, Gørtz S, Feenstra B, Duno M, Juncker I, Eiberg H, Vissing J, Wohlfahrt J, Melbye M (2014) Risk of cancer in relatives of patients with myotonic dystrophy: a population-based cohort study. Eur J Neurol 21:1192–1197
18. Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11:891–905
19. Thornton CA (2014) Myotonic dystrophy. Neurol Clin 32:705–719
20. Mueller CM, Hilbert JE, Martens W, Thornton CA, Moxley RT 3rd, Greene MH (2009) Hypothesis: neoplasms in myotonic dystrophy. Cancer Causes Control 20:2009–2020
21. Santoro M, Masciullo M, Bonvissuto D, Bianchi ML, Michetti F, Silvestri G (2013) Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2. Mol Cell Biochem 380:259–265
22. Belfiore A, Malaguarnera R (2011) Insulin receptor and cancer. Endocr Relat Cancer 18:R125–R147
23. Perbellini R, Greco S, Sarra-Ferraris G, Cardani R, Capogrossi MC, Meola G, Martelli F (2011) Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord 21:81–88
24. Cheng Q, Yi B, Wang A, Jiang X (2013) Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis. Onco Targets Ther 6:1675–1684
25. Pallante P, Battista S, Pierantoni GM, Fusco A (2014) Deregulation of microRNA expression in thyroid neoplasias. Nat Rev Endocrinol 10:88–101
26. Schuler S, Ponnath M, Engel J, Ortmann O (2013) Ovarian epithelial tumors and reproductive factors:a systematic review. Arch Gynecol Obstet 287:1187–1204
27. Anderson KN, Schwab RB, Martinez ME (2014) Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 144:1–10
28. Kim JJ, Chapman-Davis E (2010) Role of progesterone in endometrial cancer. Semin Reprod Med 28:81–90
29. Ørngreen MC, Arlien-Søborg P, Duno M, Hertz JM, Vissing J (2012) Endocrine function in 97 patients with myotonic dystrophy type 1. J Neurol 259:912–920
30. Srebnik N, Margalioth EJ, Rabinowitz R, Varshaver I, Altarescu G, Renbaum P, Levi-Lahad E, Weintraub A, Eldar-Geva T (2014) Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy. Reprod Biomed Online 29:94–101